Skip to main content
. 2021 Jan;1866(1):158823. doi: 10.1016/j.bbalip.2020.158823

Fig. 2.

Fig. 2

Plasma concentrations of major FFA species in T1DM and control individuals measured by GC–MS. A. Typical GC–MS chromatogram showing FAME separation. B-M. Plasma concentrations of B. myristate (14:0), C. palmitoleate (16:1), D. palmitate (16:0), E. α-linolenate (18:3), F. linoleate (18:2), G. oleate (18:1c9), H. cis-vaccenate (18:1c11), I. stearate (18:0), J. eicosapentaenoate (20:5), K. arachidonate (20:4), L. dihomo-γ-linolenate (20:3) and M. docosahexaenoate (22:6) are presented for subjects with T1DM and controls. Plasma FFA concentrations were reduced in the T1DM group compared to the control group (p < 0.0001 for myristate, linoleate, oleate, cis-vaccenate, stearate and docosahexaenoate, p = 0.0020 for eicosapentaenoate, p = 0.0068 for arachidonate), except for α-linolenate and dihomo-γ-linolenate, which were not significantly changed. Statistically significant differences are indicated by * where p < 0.05, ** where p < 0.01 and *** where p < 0.001. Where no significant differences were observed (p > 0.05), it is denoted by ns.